BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 24418725)

  • 1. Quantification of vascular tortuosity as an early outcome measure in oxygen induced retinopathy (OIR).
    Scott A; Powner MB; Fruttiger M
    Exp Eye Res; 2014 Mar; 120():55-60. PubMed ID: 24418725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary study of retinal pathological features in preterm birth pups exposed to an animal model of oxygen-induced retinopathy in mice.
    Chu ZJ; Dou GR; Wang YS; Qu XJ; Zhang Y
    Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1937-43. PubMed ID: 23740517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphomannopentaose sulfate (PI-88) suppresses angiogenesis by downregulating heparanase and vascular endothelial growth factor in an oxygen-induced retinal neovascularization animal model.
    Liang XJ; Yuan L; Hu J; Yu HH; Li T; Lin SF; Tang SB
    Mol Vis; 2012; 18():1649-57. PubMed ID: 22773903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy.
    Liu N; Chen L; Cai N
    Int J Clin Exp Pathol; 2015; 8(5):4990-8. PubMed ID: 26191192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy.
    Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased retinal neovascularization in Fas ligand-deficient mice.
    Davies MH; Eubanks JP; Powers MR
    Invest Ophthalmol Vis Sci; 2003 Jul; 44(7):3202-10. PubMed ID: 12824272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences between rat strains in models of retinopathy of prematurity.
    Floyd BN; Leske DA; Wren SM; Mookadam M; Fautsch MP; Holmes JM
    Mol Vis; 2005 Jul; 11():524-30. PubMed ID: 16052168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing of S100A4, a metastasis-associated protein, inhibits retinal neovascularization via the downregulation of BDNF in oxygen-induced ischaemic retinopathy.
    Cheng G; He T; Xing Y
    Eye (Lond); 2016 Jun; 30(6):877-87. PubMed ID: 26987588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity.
    Kociok N; Krohne TU; Poulaki V; Joussen AM
    Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):258-66. PubMed ID: 16741710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M2 Macrophages Enhance Pathological Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy.
    Zhou Y; Yoshida S; Nakao S; Yoshimura T; Kobayashi Y; Nakama T; Kubo Y; Miyawaki K; Yamaguchi M; Ishikawa K; Oshima Y; Akashi K; Ishibashi T
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4767-77. PubMed ID: 26218904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy.
    Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification.
    Banin E; Dorrell MI; Aguilar E; Ritter MR; Aderman CM; Smith AC; Friedlander J; Friedlander M
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2125-34. PubMed ID: 16639024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Captopril and vascular endothelial growth factor in a mouse model of retinopathy.
    Higgins RD; Yan Y; Geng Y; Sharma J; Barr SM
    Curr Eye Res; 2003 Aug; 27(2):123-9. PubMed ID: 14632165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous assessment of aberrant retinal vascularization, thickness, and function in an in vivo mouse oxygen-induced retinopathy model.
    Mezu-Ndubuisi OJ; Adams T; Taylor LK; Nwaba A; Eickhoff J
    Eye (Lond); 2019 Mar; 33(3):363-373. PubMed ID: 30209267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects and Mechanism of Action of PX-478 in Oxygen-Induced Retinopathy in Mice.
    Pan X; Lv Y
    Ophthalmic Res; 2020; 63(2):182-193. PubMed ID: 31955159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7, 8-Dihydroxyflavone, a TrkB receptor agonist, provides minimal protection against retinal vascular damage during oxygen-induced ischemic retinopathy.
    Zaitoun IS; Song YS; Suscha A; El Ragaby M; Sorenson CM; Sheibani N
    PLoS One; 2021; 16(12):e0260793. PubMed ID: 34855884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF isoforms and their expression after a single episode of hypoxia or repeated fluctuations between hyperoxia and hypoxia: relevance to clinical ROP.
    McColm JR; Geisen P; Hartnett ME
    Mol Vis; 2004 Jul; 10():512-20. PubMed ID: 15303088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of CD24 in angiogenesis in a mouse model of oxygen-induced retinopathy.
    Newman H; Shapira S; Spierer O; Kraus S; Rosner M; Pri-Chen S; Loewenstein A; Arber N; Barak A
    Curr Eye Res; 2012 Jun; 37(6):532-9. PubMed ID: 22577772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S100A4 gene silencing in oxygen-induced ischemic retinopathy inhibits retinal neovascularization via down-regulation of CREB expression.
    Cheng G; Tian K; Zhang L; Yang N; Xing Y; He T
    Graefes Arch Clin Exp Ophthalmol; 2016 Jan; 254(1):97-108. PubMed ID: 26358273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial Membrane Protein 2 (EMP2) Promotes VEGF-Induced Pathological Neovascularization in Murine Oxygen-Induced Retinopathy.
    Sun M; Wadehra M; Casero D; Lin MC; Aguirre B; Parikh S; Matynia A; Gordon L; Chu A
    Invest Ophthalmol Vis Sci; 2020 Feb; 61(2):3. PubMed ID: 32031575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.